Mitsuru Sasako
#138,179
Most Influential Person Now
Researcher
Mitsuru Sasako's AcademicInfluence.com Rankings
Mitsuru Sasakocomputer-science Degrees
Computer Science
#6464
World Rank
#6816
Historical Rank
Computational Linguistics
#1123
World Rank
#1137
Historical Rank
Machine Learning
#2108
World Rank
#2135
Historical Rank
Artificial Intelligence
#2367
World Rank
#2407
Historical Rank
Download Badge
Computer Science
Mitsuru Sasako's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Mitsuru Sasako Influential?
(Suggest an Edit or Addition)Mitsuru Sasako's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. (2007) (2193)
- The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. (2003) (1814)
- Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers (2000) (1681)
- Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. (2010) (1458)
- Extended lymph-node dissection for gastric cancer. (1999) (1311)
- Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. (2011) (1106)
- Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. (2004) (806)
- Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. (2010) (733)
- D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. (2008) (723)
- Randomised trials in surgery: problems and possible solutions (2002) (702)
- Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. (2004) (631)
- Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. (1993) (537)
- Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria (2015) (507)
- Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. (2016) (461)
- Lymph node metastases of gastric cancer. General pattern in 1931 patients. (1989) (446)
- Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. (2006) (372)
- New method to evaluate the therapeutic value of lymph node dissection for gastric cancer (1995) (369)
- Recurrence of early gastric cancer. Follow‐up of 1475 patients and review of the Japanese literature (1993) (331)
- Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703) (2010) (323)
- Focus on gastric cancer. (2004) (303)
- Risk factors for lymph node metastasis from intramucosal gastric carcinoma (1996) (300)
- Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. (2004) (286)
- Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. (2011) (281)
- Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. (2004) (272)
- Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912 (2017) (265)
- Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer (2014) (261)
- Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer (2010) (261)
- Neoadjuvant chemotherapy with S‐1 and cisplatin followed by D2 gastrectomy with para‐aortic lymph node dissection for gastric cancer with extensive lymph node metastasis (2014) (243)
- Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma (2017) (230)
- Risk factors for surgical treatment in the Dutch gastric cancer trial (1997) (220)
- Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer (2012) (212)
- Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer (2004) (207)
- Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer (2009) (198)
- Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer (2001) (193)
- Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer (2005) (186)
- Pancreas-preserving total gastrectomy for proximal gastric cancer (1995) (182)
- Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. (2003) (159)
- Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer (2007) (159)
- Hepatic resection for metastatic tumours from gastric cancer: Analysis of prognostic factors (1994) (154)
- Endoscopic evaluation of the remnant stomach after gastrectomy: proposal for a new classification (2002) (148)
- Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. (2019) (144)
- Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma (2017) (143)
- Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. (2013) (142)
- Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. (1998) (141)
- Influence of Overweight on Surgical Complications for Gastric Cancer: Results From a Randomized Control Trial Comparing D2 and Extended Para-aortic D3 Lymphadenectomy (JCOG9501) (2007) (133)
- Treatment strategy after non‐curative endoscopic resection of early gastric cancer (2008) (132)
- Randomized controlled trial of adjuvant uracil–tegafur versus surgery alone for serosa‐negative, locally advanced gastric cancer (2007) (130)
- Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. (2013) (130)
- High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302 (2014) (129)
- Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach (2003) (128)
- Principles of surgical treatment for curable gastric cancer. (2003) (126)
- A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric Cancer (JCOG0912). (2013) (123)
- Surgical treatment for gastric cancer: the Japanese approach. (1996) (121)
- Gastric Cancer Working Group report. (2010) (117)
- Distinct gene expression-defined classes of gastrointestinal stromal tumor. (2008) (116)
- Cancer of the gastric stump following distal gastrectomy for cancer (2007) (114)
- Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma (2001) (114)
- Symptom evaluation of long-term postoperative outcomes after pylorus-preserving gastrectomy for early gastric cancer (2007) (109)
- Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF. (2002) (109)
- Computer analysis in making preoperative decisions: A rational approach to lymph node dissection in gastric cancer patients (1989) (109)
- Evaluation of the new international union against cancer TNM staging for gastric carcinoma (2000) (107)
- Influence of Surgical Resection of Hepatic Metastases From Gastric Adenocarcinoma on Long-term Survival: Systematic Review and Pooled Analysis (2016) (103)
- The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI (2017) (102)
- Overexpression of c‐erbB‐2 protein in gastric cancer. Its correlation with long‐term survival of patients (1993) (99)
- Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program (1992) (99)
- Surgical treatment of carcinoma of the gastric stump (1991) (99)
- A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A) (2017) (98)
- Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery? (1999) (97)
- Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years (2007) (97)
- Ten‐year follow‐up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia (2015) (96)
- Phase II study of preoperative chemotherapy with S‐1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210) (2013) (96)
- Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. (2006) (95)
- Early carcinoma of the gastric cardia in Japan (2000) (94)
- Outcome of pylorus‐preserving gastrectomy for early gastric cancer (2008) (93)
- Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial. (2018) (90)
- Pfetin as a Prognostic Biomarker of Gastrointestinal Stromal Tumors Revealed by Proteomics (2008) (89)
- A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002 (2017) (88)
- The outcome of surgical treatment for gastric carcinoma in the elderly. (1998) (87)
- Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples (2008) (87)
- Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer. (1994) (84)
- Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer. (1996) (84)
- The new Japanese Classification of Gastric Carcinoma: Points to be revised (1998) (83)
- Ignoring small lymph nodes can be a major cause of staging error in gastric cancer (1998) (80)
- Long‐term survival with non‐proportional hazards: results from the Dutch Gastric Cancer Trial (2005) (78)
- Follow-up of gastric cancer: a review (2006) (78)
- Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases (2012) (77)
- Hematogenous Metastasis in Gastric Cancer Requires Isolated Tumor Cells and Expression of Vascular Endothelial Growth Factor Receptor-1 (2008) (77)
- IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling (2014) (75)
- Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy (2008) (74)
- Detection of early gastric cancer: misunderstanding the role of mass screening (2006) (74)
- Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis. (2013) (73)
- Tumor load and surgical palliation in gastric cancer. (2001) (71)
- Gastric cancer surgery in the elderly without operative mortality. (2004) (71)
- Decreasing complication rates with stapled esophagojejunostomy following a learning curve (2000) (70)
- Early gastric stump cancer following distal gastrectomy. (1995) (69)
- Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial. (2019) (67)
- Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002) (2009) (67)
- Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy (2015) (66)
- Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. (1993) (66)
- Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A) (2014) (66)
- Quality control of lymph node dissection in the Dutch randomized trial of D1 and D2 lymph node dissection for gastric cancer (1998) (63)
- Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501) (2019) (63)
- Surgical Treatment of Advanced Gastric Cancer: Japanese Perspective (2007) (62)
- Gallstone Formation after Gastric Cancer Surgery (2009) (62)
- Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients (1993) (61)
- Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01. (2008) (60)
- Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study (2016) (60)
- Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2 (2011) (59)
- Treatment of early gastric cancer in the elderly patient: results of EMR and gastrectomy at a national referral center in Japan. (2005) (58)
- Extranodal metastasis is an indicator of poor prognosis in patients with gastric carcinoma (2006) (58)
- A Large-Scale Study of MT1–MMP as a Marker for Isolated Tumor Cells in Peripheral Blood and Bone Marrow in Gastric Cancer Cases (2008) (58)
- Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination (2016) (56)
- Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial. (2019) (56)
- Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer (2011) (54)
- Should systematic lymph node dissection be recommended for gastric cancer? (1998) (53)
- Difference between Carcinoma of the Lower Esophagus and the Cardia (1996) (52)
- Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer (2017) (51)
- Mode of Recurrence after Gastric Cancer Surgery (1994) (50)
- FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells (2015) (49)
- Amylase concentration of drainage fluid after total gastrectomy (1997) (49)
- R2 compared with R1 resection for gastric cancer: morbidity and mortality in a prospective, randomised trial. (1992) (48)
- Assessment of the quality of surgery within randomised controlled trials for the treatment of gastro-oesophageal cancer: a systematic review. (2015) (48)
- Risk factors for pancreas-related abscess after total gastrectomy (2005) (47)
- Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference (2015) (47)
- A phase II clinical trial of endoscopic submucosal dissection for early gastric cancer of undifferentiated type: Japan Clinical Oncology Group study JCOG1009/1010. (2013) (46)
- Quality control of surgical technique in a multicenter, prospective, randomized, controlled study on the surgical treatment of gastric cancer. (1992) (45)
- Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT. (2016) (45)
- Preoperative Oral Antibiotics and Intravenous Antimicrobial Prophylaxis Reduce the Incidence of Surgical Site Infections in Patients With Ulcerative Colitis Undergoing IPAA (2013) (45)
- Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer (2014) (44)
- TNM and Japanese staging systems for gastric cancer: how do they coexist? (2004) (43)
- Chronic pain and quality of life following open inguinal hernia repair. (2002) (43)
- Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial (2020) (43)
- Guidelines for telling the truth to cancer patients. Japanese National Cancer Center. (1998) (43)
- Management of complications after gastrectomy with extended lymphadenectomy. (2000) (42)
- Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer (2004) (41)
- Contrasting Expression Patterns of Histone mRNA and microRNA 760 in Patients with Gastric Cancer (2013) (41)
- Significance of Lavage Cytology in Advanced Gastric Cancer Patients (2010) (41)
- Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings. (2004) (41)
- Gastric lymphography and detection of sentinel nodes. (2000) (40)
- Stage migration caused by D2 dissection with para‐aortic lymphadenectomy for gastric cancer from the results of a prospective randomized controlled trial (2006) (40)
- The Clinical Significance of Vimentin-Expressing Gastric Cancer Cells in Bone Marrow (2010) (37)
- Treatment Results of Gastric Cancer Patients: Japanese Experience (1993) (37)
- [TNM-7th edition 2009 (UICC/AJCC) and Japanese Classification 2010 in Gastric Cancer. Towards simplicity and standardisation in the management of gastric cancer]. (2011) (37)
- Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer: Japan Clinical Oncology Group study (JCOG0501). (2018) (37)
- A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study). (2015) (36)
- Reevaluation of prognostic factors in gastric leiomyosarcoma. (1995) (34)
- Improving outcomes after gastroesophageal cancer resection: can Japanese results be reproduced in Western centers? (2012) (34)
- Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy (2018) (34)
- Determining prognostic factors for gastric cancer using the regression tree method (2002) (34)
- Randomized clinical trial comparing survival after D 1 or D 2 gastrectomy for gastric cancer (2013) (34)
- Comparison of the molecular genetics of c‐erb‐B2 and p53 expression in stomach cancer in Britain and Japan (1995) (33)
- Extended lymph node dissection for gastric cancer: results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases. (1997) (33)
- Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases (2008) (32)
- Phase II study of laparoscopy-assisted distal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group Study JCOG0703. (2008) (32)
- The effects of blood transfusion on the prognosis of patients with gastric cancer (1989) (32)
- Non‐ominous micrometastases of gastric cancer (1991) (31)
- Modern Surgery for Gastric Cancer — Japanese Perspective (2006) (31)
- Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial (2018) (31)
- One thousand consecutive gastrectomies without operative mortality. (2002) (31)
- Total gastrectomy for primary gastric lymphoma at stages IE and IIE: a prospective study of fifty cases. (1997) (30)
- Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood (2007) (30)
- Pancreaticoduodenectomy for advanced gastric cancer (2004) (29)
- The management of early gastric cancer. (2000) (28)
- c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. (1997) (28)
- Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry (2020) (28)
- Detection of Minimal Gastric Cancer Cells in Peritoneal Washings by Focused Microarray Analysis with Multiple Markers: Clinical Implications (2007) (28)
- Gastric carcinoma in young adults. (1996) (27)
- Impact of human epidermal growth factor receptor (EGFR) and ERBB2 (HER2) expressions on survival in patients with stage II/III gastric cancer, enrolled in the ACTS-GC study. (2011) (27)
- Risk factors for para-aortic lymph node metastasis of gastric cancer from a randomized controlled trial of JCOG9501. (2007) (27)
- Non-Randomized Confirmatory Trial of Laparoscopy-Assisted Total Gastrectomy and Proximal Gastrectomy with Nodal Dissection for Clinical Stage I Gastric Cancer: Japan Clinical Oncology Group Study JCOG1401 (2016) (27)
- Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A) (2015) (27)
- A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval. (1996) (27)
- Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia (2007) (27)
- Universalization of the operative strategy by systematic mesogastric excision for stomach cancer with that for total mesorectal excision and complete mesocolic excision colorectal counterparts (2017) (25)
- Increasing body mass index in Japanese patients with gastric cancer (2004) (25)
- Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma (JCOG0110): Analyzes of operative morbidity, operation time, and blood loss. (2010) (25)
- TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study (2017) (24)
- Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer (2014) (24)
- Node-positive mucosal gastric cancer: a follow-up study. (2001) (24)
- Functional outcomes after extended surgery for gastric cancer (2011) (24)
- Prostaglandin E(2) mediates acid-induced heartburn in healthy volunteers. (2013) (24)
- An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis (2019) (23)
- Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial (2017) (23)
- Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002) (2019) (22)
- Radical lymphadenctomy in the management of early gastric cancer (1997) (22)
- A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002. (2012) (22)
- Nd‐YAG laser for general surgery (1985) (22)
- Incidence of lymph node metastasis in intramucosal gastric cancer measuring 30 mm or less, with ulceration; mixed, predominantly differentiated-type histology; and no lymphovascular invasion: a multicenter retrospective study (2016) (22)
- TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study. (2017) (21)
- The prognostic significance of isolated tumor cells in the lymph nodes of gastric cancer patients (2010) (21)
- Gastrointestinal cancer: Adjuvant chemotherapy after D2 gastrectomy for gastric cancer (2012) (20)
- Correlation between the length of the pyloric cuff and postoperative evaluation after pylorus-preserving gastrectomy (2010) (19)
- Role of surgery in multidisciplinary treatment for solid cancers (2004) (19)
- Progress in the treatment of gastric cancer in Japan over the last 50 years (2020) (19)
- Lymphadenectomy for gastric cancer in clinical trials: Update (1995) (19)
- [Preoperative skin preparation. A prospective study comparing a depilatory agent in shaving]. (1987) (19)
- 2221 Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer; short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG 0501) (2015) (19)
- Treatment Approaches to Esophagogastric Junction Tumors (2013) (19)
- A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial). (2011) (18)
- The Prognostic Impact of Isolated Tumor Cells in Lymph Nodes of T2N0 Gastric Cancer: Comparison of American and Japanese Gastric Cancer Patients (2009) (18)
- Overexpression of Ephrin A2 receptors in cancer stromal cells is a prognostic factor for the relapse of gastric cancer (2015) (18)
- A phase II study of preoperative chemotherapy (CX) with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancer: JCOG 0210 (2007) (18)
- Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer (2013) (18)
- Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma (JCOG0110): Final survival analysis. (2015) (18)
- HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial) (2015) (18)
- Surgical treatment for gastric leiomyosarcoma. (1998) (17)
- D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial. (2021) (17)
- Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer (2016) (17)
- Therapeutic strategies in gastric cancer. (2003) (17)
- Radical lymphadenectomy in the management of early gastric cancer. (1997) (16)
- Randomized phase III trial of standard D2 versus D2 + para-aortic lymph node (PAN) dissection (D) for clinically M0 advanced gastric cancer: JCOG9501. (2006) (16)
- Primary results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001). (2017) (16)
- A phase II study of preoperative chemotherapy with S-1 (S) and cisplatin (P) followed by D3 gastrectomy for gastric cancer (GC) with extensive lymph node metastasis (ELM): Survival results of JCOG0405. (2011) (15)
- Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1 (2013) (15)
- Phase III trial to evaluate the efficacy of neoadjuvant chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with adjuvant S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA trial). (2017) (15)
- Current status of perioperative chemotherapy for locally advanced gastric cancer and JCOG perspectives. (2020) (15)
- What is reasonable treatment for gastric adenocarcinoma? (2000) (14)
- Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013). (2018) (14)
- Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world (2019) (14)
- Treatment of early gastric cancer. (1997) (14)
- Wedge resection of the stomach for gastric leiomyosarcoma (1997) (14)
- ATTRACTION-05 (ONO-4538-38/BMS CA209844): a randomized, multicenter, double-blind, placebo-controlled Phase 3 study of Nivolumab (Nivo) in combination with adjuvant chemotherapy in pStage III gastric and esophagogastric junction (G/EGJ) cancer (2017) (14)
- Distribution of the deepest penetrating point of minute submucosal gastric cancer. (2005) (14)
- Gastric cancer eastern experience. (2012) (14)
- Incidence of nodal metastasis around the superior border of the pancreas based on number of metastatic perigastric nodes (1998) (13)
- Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry) (2018) (13)
- Clinical Significance of Molecular Detection of Matrix metalloproteinase-1 in Bone Marrow and Peripheral Blood in Patients with Gastric Cancer (2012) (12)
- Recent advances in chemotherapy and chemoradiotherapy for gastrointestinal tract cancers: adjuvant chemoradiotherapy for gastric cancer (2008) (12)
- Long-term survival results of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: A multicenter phase II trial (JCOG 0703). (2015) (11)
- Clinical application of the Nd:YAG laser endoscopy (1982) (11)
- Updates on Surgical Management of Advanced Gastric Cancer: New Evidence and Trends. Insights from the First International Course on Upper Gastrointestinal Surgery—Varese (Italy), December 2, 2011 (2013) (11)
- Institutional variation in short- and long-term outcomes after surgery for gastric or esophagogastric junction adenocarcinoma: correlative study of two randomized phase III trials (JCOG9501 and JCOG9502) (2017) (11)
- Surgery and adjuvant chemotherapy (2008) (11)
- A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II. (1997) (11)
- Radical Lymphadenectomy for Gastric Cancer: A Prospective Randomized Trial in the Netherlands (1993) (11)
- Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States. (2005) (10)
- Determinant Factors on Differences in Survival for Gastric Cancer Between the United States and Japan Using Nationwide Databases (2020) (10)
- Surgical treatment of gastric cancer: anatomical borders and dissection of lymph nodes. (1998) (10)
- Early gastric stump cancer following distal gastrectomy (1998) (10)
- Current Results of Randomized Studies about the Extent of Lymph Node Dissection (1994) (10)
- Green tea and gastric cancer. (2001) (10)
- Randomized phase III study of etoposide plus cisplatin versus irinotecan plus cisplatin in advanced neuroendocrine carcinoma of the digestive system: A Japan Clinical Oncology Group study (JCOG1213). (2015) (10)
- Wert der systematischen erweiterten Lymphknotendissektion--Ergebnisse in Japan. [Value of systematic extended lymph node dissection--results in Japan]. (1992) (9)
- Solid-pseudopapillary neoplasm of the pancreas with massive central calcification in an old man. (2010) (9)
- Cancer of the stomach: A review of two hospitals in Korea and Japan (1993) (9)
- Prognostic Impact of Immune-Related Gene Expression in Preoperative Peripheral Blood from Gastric Cancer Patients (2018) (8)
- Chylous Ascites after Extended Lymphnode Dissection for Gastric Cancer. (1994) (8)
- Randomized controlled trial of comparing gastrectomy (Gx) plus chemotherapy (CTX) with CTX alone in advanced gastric cancer (AGC) with a single non-curable factor: JCOG 0705/KGCA01 study (REGATTA). (2015) (8)
- Is there role for laparoscopic gastrectomy for advanced gastric cancer. (2017) (8)
- Randomized phase III trial of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer (JCOG0912). (2019) (8)
- Report of the Eleventh International Symposium of the Foundation for Promotion of Cancer Research: Basic and Clinical Research in Gastric Cancer. (1998) (8)
- TREATMENT RESULTS OF GASTRIC CANCER PATIENTS : AN ANALYSIS OF NATIONWIDE DATABASE (1995) (7)
- Effectiveness of systematic lymph node dissection in gastric cancer surgery (2007) (7)
- Clinical outcomes of proximal gastrectomy for gastric cancer: A comparison between the double-flap technique and jejunal interposition (2021) (7)
- 626PDA randomized phase III trial comparing 4 courses and 8 courses of S-1 adjuvant chemotherapy for p-stage II gastric cancer: JCOG1104 (OPAS-1) (2017) (7)
- Clinical trials of surgical treatment of malignant diseases (2005) (7)
- Left thoraco-abdominal approach (LT) compared with abdominal and transhiatal approach (AT) for cardia or sub-cardia cancer. Results of a surgical randomized controlled trial (JCOG9502). (2004) (7)
- [Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer]. (1994) (7)
- The Gastric Cancer Treatment Guideline (2005) (7)
- Surgical treatment for gastric leiomyosarcoma clinicopathological study of 51 resected cases. (1989) (7)
- A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer (JCOG0912): Analysis of the safety and short-term clinical outcomes. (2015) (6)
- Meeting report: The 75th Congress of the Japanese Gastric Cancer Association (2004) (6)
- [Reasonable lymph node dissection in radical gastrectomy for gastric cancer: introduction of computer information system and lymphography technique by India-ink]. (1989) (6)
- A phase III trial to confirm modified S-1 adjuvant chemotherapy for pathological stage II/III vulnerable elderly gastric cancer patients who underwent gastric resection (JCOG1507, BIRDIE). (2018) (6)
- Randomized Controlled Trials on Adjuvant Therapy for Gastric Cancer: Japanese Experience (1999) (6)
- Propagermanium Induces NK Cell Maturation and Tends to Prolong Overall Survival of Patients With Refractory Cancer (2019) (6)
- [Getting informed consent in clinical trials on Japanese cancer patients]. (1996) (6)
- [Adjuvant chemotherapy using S-1 for curatively resected gastric cancer-the nationwide clinical trial]. (2006) (6)
- Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002). (2016) (6)
- [Lymph node dissection around the splenic artery for gastric cancer--a comparative study of pancreatectomy and pancreas-preserving operation]. (1992) (6)
- The Combined Use of Drainage Amylase Concentration and Serum C-reactive Protein as Predictors of Pancreas-Related Complications after Elective Gastrectomy (2019) (6)
- Dermokine expression in intraductal papillary-mucinous neoplasm and invasive pancreatic carcinoma. (2012) (5)
- Challenges in performing surgical randomized controlled trials in Japan. (2009) (5)
- Diagnosis of invasion depth in resectable advanced gastric cancer for neoadjuvant chemotherapy: An exploratory analysis of Japan clinical oncology group study: JCOG1302A. (2020) (5)
- Update on Surgery of Gastric Cancer: New Procedures versus Standard Technique (2005) (5)
- D2 nodal dissection (2003) (4)
- Effectiveness and limitations of staging laparoscopy for peritoneal metastases in advanced gastric cancer from the results of JCOG0501: A randomized trial of gastrectomy with or without neoadjuvant chemotherapy for type 4 or large type 3 gastric cancer. (2017) (4)
- An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer (GC) with extensive lymph node metastasis (ELM). (2011) (4)
- Reply to Professor Hermanek's comments on the new Japanese classification of gastric carcinoma (1999) (4)
- Report of the Seventeenth International Symposium of the Foundation for Promotion of Cancer Research: Recent Advances in Gastric Cancer. (2004) (4)
- [Treatment outcomes of patients with cervical lymph node recurrence after esophagectomy for esophageal cancer]. (2014) (4)
- Ramucirumab: second-line therapy for gastric cancer. (2014) (4)
- The Asian Perspective on the Surgical and Adjuvant Management of Esophagogastric Cancer. (2017) (4)
- One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry. (2021) (4)
- Optimizing adjuvant therapies for the treatment of gastric cancer: with a special focus on Asia (2019) (4)
- [TNM classification: cancer of the stomach]. (1998) (4)
- Interaction between intratumoral ERCC1 expression and adjuvant treatment with S-1 on the survival of patients enrolled in the ACTS-GC study. (2012) (3)
- Impact of the gene expressions of thymidylate synthase and dihydropyrimidine dehydrogenase on survival in patients enrolled in the ACTS-GC study. (2012) (3)
- Appendectomy in rabbits with extended unilateral anesthesia. (2002) (3)
- Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for advanced gastric cancer: exploratory analysis of the JCOG1001 phase III trial (2021) (3)
- Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for advanced gastric cancer: exploratory analysis of the JCOG1001 phase III trial (2021) (3)
- Subgroup analysis of JCOG0501 phase III study to confirm superiority of additional neoadjuvant chemotherapy with S-1 plus cisplatin to D2 gastrectomy with S-1 adjuvant chemotherapy for resectable type IV or large type III gastric cancer. (2019) (3)
- [Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer]. (2000) (3)
- Adjuvant chemotherapy with 5-FU or regimens including oral fluoropyrimidine for curable gastric cancer (2009) (3)
- Erratum to: Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer (2014) (3)
- Adjuvant Chemotherapy of Gastric Cancer: JCOG Experience (1999) (3)
- Local excision for early gastric cancers. (1990) (2)
- Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A (2020) (2)
- Challenges to quality assurance of surgical interventions in clinical oncology trials: A systematic review. (2020) (2)
- Computer Assisted Surgery for Gastric Cancer (1993) (2)
- Potential predictive markers of chemotherapy for advanced gastric cancer: Biomarker study in GC0301/TOP-002, randomized phase III study of irinotecan plus S-1 versus S-1. (2014) (2)
- Successful treatment of a primary gastric T-cell lymphoma lacking the human T-cell leukemia virus type 1. (2010) (2)
- A randomized phase II trial of systemic chemotherapy with or without trastuzumab followed by surgery in HER2 positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger study). (2016) (2)
- [Recent changes in informed consent for cancer treatment]. (2005) (2)
- Erratum to: Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial (2017) (2)
- [Utility and drawbacks of fludeoxyglucose-positron emission tomography in locally advanced esophageal cancer treated by neoadjuvant chemotherapy followed by esophagectomy]. (2013) (2)
- Early Detection of Gastrointestinal Cancers: Recent Progress in Endoscopy and Surgical Results (1992) (2)
- Efficacy and safety result of trastuzumab (T-mab) and paclitaxel for T-mab naive patients with HER2-positive previously treated advanced or recurrent gastric cancer (JFMC45-1102): Final report. (2014) (2)
- Risk factors for the continuation of S-1 adjuvant chemotherapy for gastric cancer analyzed from the JCOG1104 phase III trial. (2021) (2)
- [Clinical utility of PET-CT for esophageal cancer]. (2009) (2)
- Prognostic Factors for Gastric Cancer Patients — Alternation of the Significance in 6,540 Patients Treated Over a 30-Year Period (1993) (2)
- [The effect of Nd:YAG laser irradiation on gastric cancer in rats induced by N-methyl-N'-nitro-N-nitrosoguanidine as a model of endoscopic laser treatment for early gastric cancers]. (1985) (2)
- Operative Benefits of Artificial Pneumothorax in Thoracoscopic Esophagectomy in the Left Lateral Decubitus Position for Esophageal Cancer (2015) (2)
- Introduction to the surgical treatment of gastric cancer: anatomical borders and dissection of lymph nodes. (1998) (1)
- Total Gastrectomy with Radical Systemic Lymphadenectomy (Japanese Procedure) (2007) (1)
- Progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in advanced/recurrent gastric cancer (AGC) treatment: Individual-patient-data (IPD) based meta-analysis of randomized trials. (2020) (1)
- The surgical treatment of gastric cancer with special reference to systematic lymph node dissection. (1991) (1)
- [The current situation and treatment strategy for gastric cancer at the National Cancer Center of Tokyo, Japan]. (1994) (1)
- Clinical implication of using up both fluoropyrimidine (FU) and paclitaxel (PTX) in patients with severe peritoneal metastases (SPM) of gastric cancer (GC). (2021) (1)
- The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI (2017) (1)
- Prediction of the peritoneal recurrence via the macroscopic diagnosis of the serosal invasion in patients with gastric cancer: Supplementary analysis of JCOG0110. (2022) (1)
- [Clinical Outcomes of Local Therapy for Lymph Node Recurrence after Radical Esophagectomy for Esophageal Cancer]. (2016) (1)
- A Study on Gastric Cancer Treated by Non-Curative Resection (1995) (1)
- Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1 (2013) (1)
- Diagnosis of invasion depth in resectable advanced gastric cancer for neoadjuvant chemotherapy: An exploratory analysis of JCOG1302A. (2018) (1)
- [Informed consent for gastric cancer surgery]. (2007) (1)
- Determination of the optimal cutoff percentage of residual tumors to define the pathologic response rate (pathRR) of gastric cancer (GC) treated with preoperative therapy (JCOG1004-A). (2013) (1)
- Reply to B. Faltas et al (2011) (1)
- Expression analysis of MET, EGFR, and HER2, and K-ras mutation status in patients with stage II/III gastric cancer enrolled in the ACTS-GC study. (2013) (1)
- [Gastrojejunostomy for irresectable gastric cancer with pyloric stenosis-new role of surgery in the era of S-1]. (2009) (1)
- Asymptomatic Free Air Caused by Mallory-Weiss Tears during Endoscopy. (2015) (1)
- [Clinical Outcomes and Prognosis of Salvage Thoracoscopic Esophagectomy after Definitive Chemoradiotherapy]. (2015) (1)
- New Technologies in Gastric Cancer Surgery: Computer system to make operation plan and intraoperative staining of regional lymph nodes for complete dissection (1990) (1)
- Updated report of a randomized phase III trial comparing 4 and 8 courses of S-1 adjuvant chemotherapy for p-stage II gastric cancer: JCOG1104 (OPAS-1). (2018) (1)
- Docetaxel Plus Cisplatin and S-1 versus Cisplatin and S-1 in Patients with Advanced Gastric Cancer (JCOG1013): An Open-Label, Randomised, Phase 3 Trial (2019) (1)
- Impact of tumor-related factors and inter-institutional heterogeneity on preoperative T staging for gastric cancer. (2022) (1)
- Abstract 5201: MicroRNA 760 regulates gastric cancer progression by downregulation of histone mRNA expression (2014) (1)
- [Surgical treatment of perforated diverticular sigmoiditis. A retrospective study apropos of 45 cases]. (1989) (1)
- A phase III trial to confirm the superiority of S-1 adjuvant chemotherapy for vulnerable elderly patients with pathological stage II/III gastric cancer after curative resection: JCOG1507 (BIRDIE). (2018) (1)
- [Two Resected Cases with Superficial Basaloid Squamous Carcinoma of the Esophagus]. (2016) (1)
- Long-term outcome of preoperative docetaxel with cisplatin plus S-1 therapy for advanced gastric cancer with extensive nodal metastasis (JCOG1002). (2019) (1)
- Three-year outcomes of two phase II studies of adjuvant chemotherapy with S-1 plus oxaliplatin or capecitabine plus oxaliplatin in patients with stage III gastric cancer after D2 gastrectomy. (2018) (1)
- Identification of prognostic biomarkers for gastric cancer by gene expression analysis (2007) (1)
- Corrigendum to: Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry (2020) (1)
- [Problems of international standardization of gastric cancer surgery]. (2001) (1)
- Stemness signature of BMI1 and clinical outcome in esophageal cancer patients undergoing neoadjuvant chemoradiotherapy. (2009) (1)
- Reply: molecular determinants of prognosis in oesophageal cancer patients treated with chemoradiation (2008) (1)
- A QUESTIONNAIRE SURVEY ON CANDIDATES FOR PALLIATIVE GASTRIC RESECTION FOR NON -CURATIVE GASTRIC CANCER (2005) (1)
- A phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by gastrectomy with D2 plus para-aortic lymph node (PAN) dissection for gastric cancer with extensive lymph node metastasis (ELM): Japan Clinical Oncology Group Study JCOG1002. (2015) (1)
- Two Cases of Gastric Adenocarcinomas after the Remission of Gastric Malignant Lymphoma treated by Chemo-Radiotherapy (2008) (1)
- WHO histological classification of gastric tumours1 (2012) (1)
- Non-Anatomical Prognostic Factors for Gastric Cancer Patients: Significance of Tumor Markers (1993) (1)
- Indications for local resection for gastric leiomyosarcoma (1995) (1)
- Optimal Timing to Assess Drain Amylase Concentration after Elective Gastrectomy (2021) (1)
- [Informed consent for surgical treatment of gastric cancer]. (2001) (0)
- Role of reduction gastrectomy in patients with gastric cancer with a single non‐curable factor: Supplementary analysis of REGATTA trial (2023) (0)
- Study on deep vein thrombosis (DVT) risk factors at the time of cancer diagnosis in patients from the multicenter, prospective Cancer-Venous Thromboembolism (VTE) Registry. (2020) (0)
- Working Report-Gastric Cancer Surgical Treatment and Adjuvant Therapy for Curable Advanced Gastric Cancer (2009) (0)
- 1475P Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for cT3/4a gastric cancer - Exploratory analysis of JCOG1001 study (2020) (0)
- 1399P Risk factors for body weight loss after gastrectomy for gastric cancer analysed from the JCOG1001 phase III trial (2021) (0)
- Surgical Treatment: Multicenter, Surgical, Clinical Trials (2012) (0)
- Role of volume reduction gastrectomy according to tumor location in patients with gastric cancer with a single noncurable factor: REGATTA trial (JCOG0705/KGCA01) supplementary analysis. (2019) (0)
- 1417P Prediction of the peritoneal recurrence by macroscopic diagnosis of the serosal invasion in gastric cancer: Supplementary analysis of JCOG0110 study (2021) (0)
- The General Rule of the Japanese Research Society for Gastric Cancer and Treatment Results by the Rule (1990) (0)
- A Case of Para-aortic Lymph Node Metastasis of Mucosal Gastric Carcinoma that Occurred 6 Years after Surgery (2021) (0)
- Adjuvant and Neoadjuvant Treatment: Standard Treatment and Clinical Trials in the East (2015) (0)
- Survival results by the prospectively determined clinical staging for locally advanced gastric cancer: An ancillary study of JCOG1302A (JCOG1302A2). (2023) (0)
- Experience of a continuous open peritoneal irrigation for massive arterial bleeding due to pancreatic fistula or anastomotic leakage after surgery for gastric cancers. (1991) (0)
- Surgical Resection of the Stomach with Lymph Node Dissection (2005) (0)
- 1122 A phase III trial to confirm preventing effects of perioperative enteral EPA-enriched immunonutrition on body weight loss after total gastrectomy for gastric cancer (2015) (0)
- Band 15, Heft 3, September 1999 (1999) (0)
- P69 Standardization in a surgical trial (1993) (0)
- Contents Vol. 22, 2004 (2005) (0)
- Isolated Tumor Cells in Lymph Nodes of Patients with Gastric Cancer (2009) (0)
- [A Meaning for incurable patients to know the truth of their disease]. (1997) (0)
- Superior lumbar hernia after gastrectomy repaired via an open approach in the prone position: A case report (2020) (0)
- Health-related quality-of-life results from JCOG0912: A phase III noninferiority trial comparing open and laparoscopy-assisted distal gastrectomy for stage I gastric cancer. (2020) (0)
- [Clinical outcomes of thoracoscopic esophagectomy after neoadjuvant chemotherapy]. (2013) (0)
- Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort. (2023) (0)
- Risk factors for recurrence in each pattern after curative gastrectomy for pStage II/III gastric cancer: An exploratory analysis of a randomized controlled trial (JCOG1001). (2021) (0)
- Stage Migration in Gastric Cancer: Its Influence on Survival Rates (1999) (0)
- Guideline for clinical safety data management in Japan Clinical Oncology Group (JCOG) (version 4) (2001) (0)
- A CASE OF CONGENITAL BILIARY DILATATION WITH ASSOCIATED CARCINOMA OF THE GALLBLADDER (1979) (0)
- Is the ISGPS definition of pancreatic fistula applicable after gastrectomy? (2022) (0)
- Proceedings of the 25th annual meeting From October 13–15, 1983—Yamaguchi, Japan (1984) (0)
- [Present state and prospects of adjuvant chemotherapy for gastric cancer]. (2011) (0)
- Effects of perioperative enteral EPA-enriched immunonutrition on meaningful loss of lean body mass after total gastrectomy for gastric cancer: Post hoc analysis of a phase III study. (2016) (0)
- CLINICAL ASPECTS OF MARGINAL ZONE LYMPHOMA (1997) (0)
- Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013. (2021) (0)
- A Case of a Gastric Submucosal Tumor after Hepatectomy Performed Six Years Previously (2015) (0)
- Impacts of cancer-associated stromal cells on growth of human gastric cancer cell lines (2015) (0)
- Subject Index Vol. 22, 2004 (2005) (0)
- YAG laser treatment of gastric cancer (1982) (0)
- Human Cancer Biology Contrasting Expression Patterns of Histone mRNA and microRNA 760 in Patients with Gastric Cancer (2013) (0)
- EP1376: ANTIADHESION MEMBRANE IS NOT EFFECTIVE IN THE PREVENTION OF SMALL BOWEL OBSTRUCTION AFTER OPEN GASTRECTOMY FOR GASTRIC CANCER: A SUPPLEMENTAL ANALYSIS OF THE MULTICENTER RANDOMIZED CONTROLLED TRIAL JCOG1001 (2022) (0)
- The association of renal function with safety and efficacy of cisplatin plus S-1 (CS) therapy and docetaxel plus cisplatin plus S-1 (DCS) therapy in patients with advanced gastric cancer (AGC): An additional analysis of JCOG1013. (0)
- The association of renal function with safety and efficacy of cisplatin plus S-1 (CS) therapy and docetaxel plus cisplatin plus S-1 (DCS) therapy in patients with advanced gastric cancer (AGC): An exploratory analysis of JCOG1013. (2021) (0)
- [Prevention of gastric stump carcinoma]. (2001) (0)
- [Current topics of adjunct therapy for stomach cancer after surgery]. (2008) (0)
- [Practice guidelines in western countries]. (1999) (0)
- 1397P Prognostic impact of infectious complications: Exploratory analysis of JCOG0501 phase III trial (2021) (0)
- MESUREMENT OF FIBRINOGEN DEGENERATIVE PRODUCT (FDP) AS A USEFUL EXAMINATION TO SCREEN PATIENTS WHO MIGHT HAVE BONE AND/OR BONE MARROW METASTASIS FROM GASTRIC CANCER (1992) (0)
- Role of volume reduction gastrectomy according to tumor location in patients with gastric cancer with a single non-curable factor: Supplementary analysis of REGATTA trial (JCOG0705/KGCA01). (2018) (0)
- Final results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001). (2021) (0)
- Association of gene expressions of TOP2A, GGH, and PECAM1 with hematogenous, lymph-node, and peritoneal recurrence in patients with stage II/III gastric cancer enrolled in the ACTS-GC study. (2013) (0)
- Early Detection of Gastric Adenocarcinoma: The Key to Reduce or an Illusion? (1998) (0)
- A case of pulmonary leiomyosarcoma achieving long-term survival after multiple metastasectomies (2022) (0)
- [A Case of Stage IV Gastric Cancer Which Showed Pathological Complete Response after Neo-Adjuvant Chemotherapy]. (2018) (0)
- Surrogate indicators of survival in patients who received neoadjuvant chemotherapy for type 4 and large type 3 gastric cancer in JCOG0501. (2020) (0)
- Quantitative evaluation of heterogeneities in treatment effects and baseline risks among hospitals from a phase III surgical trial of gastric cancer (2007) (0)
- The Amount and Concentration of Drain Amylase Together Predict Postoperative Pancreatic Fistula after Gastric Cancer Surgery More Accurately than the Concentration Alone (2022) (0)
- Gastrectomy with D3 Lymph Node Dissection (2019) (0)
- Metastasis to Minute Lymph Node in Gastric Cancer, Its Significance for Indication of Endoscopic or Local Surgical Treatments (1993) (0)
- Clinicopathological and Endoscopic Studies on Gastric Cancer Located; the Cardia (1991) (0)
- Authors' reply (2001) (0)
- FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells (2015) (0)
- Early detection of gastric adenocarcinoma: the key to reduce mortality or an illusion? (1998) (0)
- Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial (2018) (0)
- Recurrence patterns after curative gastrectomy for pStage II/III gastric cancer: Exploratory analysis of the randomized controlled JCOG1001 trial. (2022) (0)
- Summaries from The 60th Annual Meeting of the Japan Esophageal Society June 30ĐJuly 1, 2006, Tokyo (2006) (0)
- Impact of insulin-like growth factor 1 receptor (IGF1R) and amphiregulin (AREG) expressions on survival in patients with stage II/III gastric cancer enrolled in the ACTS-GC study. (2012) (0)
- Health-related quality-of-life assessment in accordance with reconstruction procedures for distal gastrectomy for stage I gastric cancer using data from JCOG0912. (2020) (0)
- Prognostic impact of PD-1, PD-L1, and CD8 genes expression in peripheral blood in gastric cancer. (2017) (0)
- Reply to F. Crea et al (2011) (0)
- How should pain be controlled in clinical trials for pancreatic cancer? (1996) (0)
- Nishi Memorial Award in Gastric Cancer (2010) (0)
- Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor: Exploratory analysis in the patients who were enrolled in JCOG0705/KGCA01 phase III trial (REGATTA) and could continue chemotherapy (2019) (0)
- Total Gastrectomy with Radical Systemic Lymphadenectomy (Classic Japanese Style D2) (2016) (0)
- Cost-effectiveness of adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for curatively resected gastric cancer (2008) (0)
- Short Term Operative Outcomes of Laparoscopic Gastric Mobilization in Esophagectomy for Esophageal Cancer: Comparison with Hand Assisted Technique (2016) (0)
- Five-year follow-up of a randomized clinical trial comparing bursectomy and omentectomy alone for resectable gastric cancer (JCOG1001). (2022) (0)
- comparison of the laser photocoagulation and the electrocoagulation for the hemostasis of the canine gastric ulcer bleeding (1980) (0)
- [Surgical treatment for gastric cancer in western countries]. (2001) (0)
- Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mitsuru Sasako?
Mitsuru Sasako is affiliated with the following schools:
